HyperFlex Medical, developer of the HyperFlex Bunion Correction System, closed a $1.4 million investment from Easton Capital.
HyperFlex realigns and stabilizes the first and second metatarsals using a flexible implant, eliminating the need for bone cutting or fusion. Patients can often bear weight immediately. The system may offer significant reductions in operating time and complication rates compared to traditional methods, with seamless integration into existing workflows.
The investment will be provided in two tranches: an initial $700,000 and an additional $700,000 upon achieving specific milestones. These funds will accelerate the development of HyperFlex, expand the team and drive commercial rollout, supporting adaptable, workflow-friendly innovations for broader market reach.
“Easton Capital’s support will accelerate the launch of HyperFlex,” said Bob Peterhans, HyperFlex Medical CEO. “Our technology addresses the vast majority of bunion patients who previously had no suitable early-stage options. This partnership enables us to bring HyperFlex to more surgeons and patients. We are committed to delivering better outcomes in bunion care.”
HyperFlex Medical, developer of the HyperFlex Bunion Correction System, closed a $1.4 million investment from Easton Capital.
HyperFlex realigns and stabilizes the first and second metatarsals using a flexible implant, eliminating the need for bone cutting or fusion. Patients can often bear weight immediately. The system may offer significant...
HyperFlex Medical, developer of the HyperFlex Bunion Correction System, closed a $1.4 million investment from Easton Capital.
HyperFlex realigns and stabilizes the first and second metatarsals using a flexible implant, eliminating the need for bone cutting or fusion. Patients can often bear weight immediately. The system may offer significant reductions in operating time and complication rates compared to traditional methods, with seamless integration into existing workflows.
The investment will be provided in two tranches: an initial $700,000 and an additional $700,000 upon achieving specific milestones. These funds will accelerate the development of HyperFlex, expand the team and drive commercial rollout, supporting adaptable, workflow-friendly innovations for broader market reach.
“Easton Capital’s support will accelerate the launch of HyperFlex,” said Bob Peterhans, HyperFlex Medical CEO. “Our technology addresses the vast majority of bunion patients who previously had no suitable early-stage options. This partnership enables us to bring HyperFlex to more surgeons and patients. We are committed to delivering better outcomes in bunion care.”
Copy to clipboard 
